COVID Update: Masks are still required in health care settings, even if you’re fully vaccinated. Read our FAQs.

Agenda Clinical Hematology & Oncology 2021

Saturday, February 20, 2021

Topic: Benign Hematology


7 a.m.   

Virtual Event Opens & View Exhibits


7:55 a.m.            

Welcome & Educational Overview

Michael Kosty, MD


8 a.m.   

Basic Clinical Concepts in Thrombosis Diagnosis and Management: Refresher and 22 Teaching Points 

Stephan Moll, MD

UNC School of Medicine


8:30 a.m.                

HIT Clinical “Pearls”

Theodore (Ted) Earl Warkentin, MD, BSc

McMaster University


9 a.m.                     

Sickle Cell Disease and Hemoglobinopathies: 2021 Update for the Practicing Heme-Onc Healthcare Professional

Jane Little, MD

UNC School of Medicine


9:30 a.m.              

Break, Networking & View Exhibits


9:45 a.m.               

The Most Relevant Clinical Bleeding Developments of the Last 12 Months

Alice Ma, MD

UNC School of Medicine


10:15a.m.               

Hematologic Aspects of COVID-19

Thomas Lee Ortel, MD, PhD

Duke University School of Medicine


10:45 a.m.              

Hematological Problems of Pregnancy

John Kelton, MD

McMaster University


11:15 a.m.              

Benign Hematology Panel

John Kelton, MD

Jane Little, MD

Alice Ma, MD

Stephan Moll, MD

Thomas Lee Ortel, MD, PhD

Theodore (Ted) Earl Warkentin, MD, BSc


11:45 a.m.              

Break, Networking & View Exhibits


Topic: Malignant Hematology


12:45 p.m.              

Tailoring Maintenance Therapy of Myeloma

Morie A. Gertz, MD

Mayo Clinic


1:15 p.m.               

Diffuse Large Cell Lymphoma Subtypes and Treatment

Andrew D. Zelenetz, MD, PhD

Memorial Sloan Kettering Cancer Center


1:45 p.m.                

Treatment Approaches to Mantle Cell Lymphoma

Luhua (Michael) Wang, MD

The University of Texas MD Anderson Cancer Center

                               

2:15 p.m.              

Break, Networking & View Exhibits


2:30 p.m.                

Modern Treatment Options for CLL

Anthony Mato, MD, MSCE

Memorial Sloan Kettering Cancer Center


3 p.m.                     

AML in the Older Population

Hagop M. Kantarjian, MD

The University of Texas MD Anderson Cancer Center


3:30 p.m.                

Therapeutic Updates for Follicular and Marginal Zone Lymphoma

Loretta J. Nastoupil, MD

The University of Texas MD Anderson Cancer Center


4 p.m.                     

Malignant Hematology Panel

Hagop M. Kantarjian, MD

Loretta J. Nastoupil, MD

Luhua (Michael) Wang, MD


4:30 p.m.                

Adjourn

Sunday, February 21, 2021

Topic: Solid Tumor Oncology


6:45 a.m.   

Virtual Event Opens & View Exhibits


7:40 a.m.

Welcome & Morning Announcements


7:45 a.m.   

The Race Toward Equity: Increasing Racial Diversity in Cancer Research and Cancer Care 

Lori J. Pearce, MD

University of Michigan


8:15a.m.                

The Evolving Paradigm of Melanoma Treatment

Janice Mehnert, MD

NYU Langone Health


8:45 a.m.                     

Immunotherapy and Targeted Therapy in Upper GI Cancers

Sam Klempner, MD

Massachusetts General Hospital


9:15 a.m.                

Break, Networking & View Exhibits


9:30 a.m.                   

How to Prioritize the Many Therapeutic Options for HER2+ Metastatic Breast Cancer

Debasish Tripathy, MD

The University of Texas MD Anderson Cancer Center


10 a.m.              

Management of Non-Clear Cell RCC

Sumanta Kumar Pal, MD

City of Hope


10:30 a.m.                  

Updates in NSCLC with Emphasis on Front Line Therapy

Suresh S. Ramalingam, MD

Emory Winship Cancer Institute


11 a.m.

Solid Tumor Oncology Panel Part 1

Janice Mehnert, MD

Sam Klempner, MD

Suresh S. Ramalingam, MD

Debasish Tripathy, MD


11:30 a.m.              

Break, Networking & View Exhibits


12:30 p.m.              

Targeted Approaches in Sarcoma

Arun S. Singh, MD

University of California, Los Angeles Health


1 p.m.                  

Bernard Lee Schwartz Cancer Lectureship

Optimizing Immunotherapy for Metastatic Breast Cancer

Heather L. McArthur, MD, MPH

Cedars-Sinai Medical Center


1:30 p.m.                

Practical Aspects of Novel Imaging Approaches in the Management of Prostate Cancer

Jeremie Calais, MD, MSc

University of California, Los Angeles


2 p.m.                     

Break, Networking & View Exhibits


2:15 p.m.                

Update on Systemic Therapies for Thyroid Cancer

Eric J. Sherman, MD

Memorial Sloan Kettering Cancer Center


2:45 p.m.                

New Approaches to Recurrent or Advanced Bladder Cancer

Dean F. Bajorin, MD

Memorial Sloan Kettering Cancer Center


3:15 p.m.                

The Evolving Role of Liquid Biopsies

David R. Gandara, MD

University of California Davis Comprehensive Cancer


3:45 p.m.                

Solid Tumor Oncology Panel

Jeremie Calais, MD, MSc

Heather L. McArthur, MD, MPH

Eric J. Sherman, MD

Arun S. Singh, MD


4:15 p.m.                

Main Conference Final Adjournment


Please note: All times listed are Pacific Standard Time (PST)